Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,178,164
+$1,969,482 QoQ
Shares Held
2,154,499
-26.8% QoQ
Ownership
0.670%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Derivatives in MNKD
reported options exposure · as of Sep 30, 2025CallValue
$805,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. MNKD ranks #160 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in MNKD
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,178,164 | 2,154,499 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,208,682 | 2,942,320 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,897,551 | 1,921,967 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $805,500 | 150,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $10,471,009 | 1,949,909 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,745,311 | 1,536,180 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,442,753 | 1,479,673 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $14,535,734 | 2,260,612 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,923,888 | 2,213,655 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,346,355 | 1,790,490 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,405,670 | 1,193,305 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,076,032 | 3,042,867 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $11,178,296 | 2,706,610 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,736,574 | 1,409,478 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $6,553,926 | 1,598,519 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $6,153,239 | 1,167,598 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $5,706,883 | 1,846,888 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $700,194 | 226,600 | Put | Defined | 2024-05-14 | |
| 2022-06-30 | $863,346 | 226,600 | Put | Defined | 2024-05-14 | |
| 2022-06-30 | $9,446,963 | 2,479,518 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $6,796,656 | 1,846,918 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,945,240 | 1,589,300 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,176,838 | 1,419,963 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,588,750 | 475,000 | Put | Defined | 2021-08-13 | |
| 2021-06-30 | $13,388,474 | 2,456,601 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,094,357 | 1,044,479 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,563,208 | 499,428 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $681,568 | 362,537 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $503,398 | 287,657 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $277,258 | 269,184 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||